PEPTIDES·INDEX
79 peptides463 listingsUpdated 3h agoBuild My Stack
Library

GHK-Cu / KPVCosmetic / Skin

GHK-Cu + KPV blend combining a copper skin peptide with an anti-inflammatory tripeptide.

Healing & RecoveryBlend
Rating1/5SpeculativeHuman dataSafety
StatusResearch only
Guided + AI

Get a research stack matched to your goals.

Answer a few quick questions — our AI builds your stack, then prices it across every vendor for the lowest total. ~3 min

Build your stack

Overview

GHK-Cu / KPV (sold under names such as "HALO") is a two-peptide blend in one vial: GHK-Cu, a copper-binding tripeptide researched for skin repair and collagen, and KPV, an alpha-MSH-derived tripeptide researched for anti-inflammatory effects. No study of the combination has been published, so any evidence is per component: GHK-Cu has mostly lab data plus small topical skin studies, and KPV has cell and animal data only. It is not FDA-evaluated and is sold for laboratory research only; nothing here is medical or dosing advice.

Evidence

Anecdotal reports community-reported

What people describe in forums, blogs and uncontrolled clinic write-ups — experiential and unverified, not clinical evidence and not medical advice.

  • KPV takes the sting out of GHK-Cucommonly reported

    The most repeated reason for the pairing is comfort: users who reconstitute 10–20 mg of KPV into a 50 mg GHK-Cu vial, or draw both into one syringe, say the copper peptide's burn and welts largely disappear; one noticed the sting return the week they ran out of KPV. Some report no reaction and admit they may simply not react to GHK-Cu. An experienced user says KPV prevents site reactions less reliably than BPC-157.

  • Skin, hair, swallowing and recovery over 90 daysoccasionally reported

    One detailed three-month log reports a fuller beard and hairline from week six, less facial redness and puffiness, faster gym recovery and a slow easing of eosinophilic oesophagitis symptoms; the user stayed on swallowed fluticasone throughout and says the two cannot be separated. A reply credits KPV with calming reflux throat spasms that maximal PPIs had not, while seeing little from GHK-Cu beyond firmer skin.

  • A BPC-free alternative to KLOW for long-term usea sizeable minority

    Users who finished a two-month KLOW cycle describe moving to the two-peptide blend 'for long term', saying these two are all they need, that they avoid BPC-157 over cancer or angiogenesis worries, and that the pair needs no cycling. Others ask why not just buy KLOW or GLOW, or note that two spare vials mixed at home cost less than a premixed 'Beauty blend'. Nobody reports a head-to-head difference in results.

  • Fixed ratio, copper breakouts and under-dosed KPVcommonly reported

    Gut-focused users are told the KPV is the part that matters and GHK-Cu at 24 does little, so a blend mostly buys one injection instead of two. The recurring objection is the ratio: the vial's proportion is what you get; only separate vials let you change one thing at a time. Copper 'uglies', a burst of breakouts in the first days, are reported; one user paused, restarted at 500 mcg GHK-Cu and built back to 1.7 mg.

  • Can the two be mixed at all?commonly reported

    First-time buyers ask whether GHK-Cu can share a vial or syringe with anything. Most say yes, citing KLOW and the premixed blend as proof and reporting no trouble mixing at reconstitution or in the barrel; a minority argue pH differences can strip the copper, that commercial blends carry buffers a home mix lacks, and that drawing from two vials risks contamination. Nobody reports a visible failure of a home mix.

Related guides

Sources

Starting references for the library summary. These are not dosing instructions or medical advice.

Prices

Compare GHK-Cu / KPV prices across vendors.

Compare prices — from $44.10

For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.